DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depakene (Valproic Acid) - Confusional State - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Confusional State (25)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) where reactions include confusional state. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Depakene side effects in 3 year old male

Reported by a consumer/non-health professional from China on 2012-08-23

Patient: 3 year old male

Reactions: Confusional State, Trismus, Epilepsy, Convulsion

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2012-03-01
    End date: 2012-08-01

Depakene
    Administration route: Oral
    Start date: 2012-08-01
    End date: 2012-08-15



Possible Depakene side effects in 46 year old male

Reported by a physician from Korea, Republic of on 2012-08-09

Patient: 46 year old male

Reactions: Confusional State, Abnormal Behaviour, Cognitive Disorder, Memory Impairment, Disorientation, Somnolence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 1000 mg
    Start date: 2012-01-01

Keppra
    Dosage: unknown dose
    Start date: 2012-01-01

Oxcarbazepine
    Start date: 2012-04-12

Topamax
    Dosage: 50 mg
    Start date: 2012-01-01
    End date: 2012-01-01

Other drugs received by patient: Zobirax; Desamethasone; Zobirax; Desamethasone



Possible Depakene side effects in 58 year old female

Reported by a physician from Belgium on 2012-07-19

Patient: 58 year old female, weighing 99.0 kg (217.8 pounds)

Reactions: Confusional State, Sedation, Hyperammonaemia, Toxicity To Various Agents, Somnolence, Hepatic Enzyme Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Zestril; Levothyroxine Sodium; Angeliq; Redomex; Lamotrigine; Duragesic-100; Zantac; Novorapid; Clonazepam; Depakene; Lamotrigine; Sulfarlem S 25; Seroquel; Fenofibrate; Zocor; Calcium Carbonate; Abilify; D-Cure; Tenormin; Metformin HCL; Lantus



Possible Depakene side effects in 78 year old female

Reported by a pharmacist from Spain on 2012-07-11

Patient: 78 year old female

Reactions: Confusional State, Hyponatraemia, Platelet Count Decreased, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-03

Patient: 46 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Confusional State, Multiple Drug Overdose Intentional, Self Injurious Behaviour, Sopor

Drug(s) suspected as cause:
Alprazolam
    Administration route: Oral
    Indication: Multiple Drug Overdose Intentional
    Start date: 2012-04-21
    End date: 2012-04-21

Depakene
    Administration route: Oral
    Indication: Multiple Drug Overdose Intentional
    Start date: 2012-04-21
    End date: 2012-04-21

Fluvoxamine Maleate
    Administration route: Oral
    Indication: Multiple Drug Overdose Intentional
    Start date: 2012-04-21
    End date: 2012-04-21

Risperidone
    Administration route: Oral
    Indication: Multiple Drug Overdose Intentional
    Start date: 2012-04-21
    End date: 2012-04-21

Topamax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-21
    End date: 2012-04-21



Possible Depakene side effects in 33 year old male

Reported by a consumer/non-health professional from Italy on 2012-04-02

Patient: 33 year old male

Reactions: Dysarthria, Confusional State, Self-Medication

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-24
    End date: 2012-03-24

Haldol
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-24
    End date: 2012-03-24



Possible Depakene side effects in 62 year old female

Reported by a physician from France on 2012-04-02

Patient: 62 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Confusional State, Lymphopenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Indication: Affective Disorder

Quetiapine Fumarate
    Administration route: Oral
    Indication: Major Depression
    Start date: 2011-12-29

Other drugs received by patient: Tercian



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-22

Patient: female

Reactions: Confusional State, Dysarthria, Antipsychotic Drug Level Increased, Hyperammonaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Delorazepam
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-07
    End date: 2011-12-13

Depakene
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-05
    End date: 2011-12-05

Depakene
    Administration route: Oral
    Start date: 2011-12-06
    End date: 2011-12-10

Depakene
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-12

Invega
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-12
    End date: 2011-12-13

Invega
    Administration route: Oral
    Start date: 2011-12-07
    End date: 2011-12-11

Lithium Carbonate
    Administration route: Oral
    Start date: 2011-12-06
    End date: 2011-12-12

Lithium Carbonate
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-05
    End date: 2011-12-05



Possible Depakene side effects in female

Reported by a physician from Italy on 2012-03-22

Patient: female

Reactions: Confusional State, Dysarthria, Hyperammonaemia, Antipsychotic Drug Level Above Therapeutic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-05
    End date: 2011-12-05

Depakene
    Dosage: form strenght: 200mg
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-12

Depakene
    Dosage: form strength; 500mg
    Administration route: Oral
    Start date: 2011-12-06
    End date: 2011-12-10

Invega
    Administration route: Oral
    Start date: 2011-12-12
    End date: 2011-12-13

Invega
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-07
    End date: 2011-12-11

Lithium Carbonate
    Administration route: Oral
    Start date: 2011-12-06
    End date: 2011-12-12

Lithium Carbonate
    Dosage: daily: 600mg, 300mg days
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-05
    End date: 2011-12-05

Other drugs received by patient: Delorazepam; Antipsychotics; Antipsychotics



Possible Depakene side effects in female

Reported by a physician from Italy on 2012-03-22

Patient: female

Reactions: Confusional State, Dysarthria, Hyperammonaemia, Antipsychotic Drug Level Above Therapeutic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antipsychotics
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-07
    End date: 2011-12-11

Antipsychotics
    Administration route: Oral
    Start date: 2011-12-12

Delorazepam
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-07
    End date: 2011-12-13

Depakene
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-05
    End date: 2011-12-05

Depakene
    Dosage: form strenght: 200mg
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-12

Depakene
    Dosage: form strength; 500mg
    Administration route: Oral
    Start date: 2011-12-06
    End date: 2011-12-10

Invega
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-07
    End date: 2011-12-11

Invega
    Administration route: Oral
    Start date: 2011-12-12
    End date: 2011-12-13

Lithium Carbonate
    Administration route: Oral
    Start date: 2011-12-06
    End date: 2011-12-12

Lithium Carbonate
    Dosage: daily: 600mg, 300mg days
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-05
    End date: 2011-12-05



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-14

Patient: female

Reactions: Confusional State, Dysarthria, Antipsychotic Drug Level Increased, Hyperammonaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Delorazepam
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-07
    End date: 2011-12-13

Depakene
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-06
    End date: 2011-12-10

Depakene
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-12

Depakene
    Administration route: Oral
    Start date: 2011-12-05
    End date: 2011-12-05

Invega
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-12
    End date: 2011-12-13

Invega
    Administration route: Oral
    Start date: 2011-12-07
    End date: 2011-12-11

Lithium Carbonate
    Administration route: Oral
    Start date: 2011-12-06
    End date: 2011-12-12

Lithium Carbonate
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2011-12-05
    End date: 2011-12-05



Possible Depakene side effects in 84 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-13

Patient: 84 year old female

Reactions: Confusional State, Orthostatic Hypotension, Drug Interaction, Dizziness, Fall, Somnolence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient possibly interacting with the suspect drug:
Depakene
    Administration route: Oral
    Start date: 2012-01-21

Lorazepam
    Dosage: daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-01-21

Other drugs received by patient: Oxazepam



Possible Depakene side effects in 29 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-28

Patient: 29 year old male

Reactions: Confusional State, Tachycardia, Pyrexia, Somnolence, Muscle Rigidity, Overdose, Gait Disturbance, Altered State of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clopixol
    Start date: 2011-11-01

Clopixol
    Indication: Childhood Psychosis
    Start date: 2009-07-01

Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-13

Lepticur

Lepticur
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-07-01

Nozinan
    Administration route: Oral
    Indication: Childhood Psychosis
    Start date: 2011-11-01

Tranxene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-23

Trimeprazine Tartrate
    Dosage: 30 drops daily
    Administration route: Oral
    Indication: Childhood Psychosis
    Start date: 2006-07-01

Trimeprazine Tartrate
    Dosage: 30 drops daily
    Administration route: Oral
    Start date: 2011-11-01

Other drugs received by patient: Tercian; Loxapine HCL



Possible Depakene side effects in female

Reported by a consumer/non-health professional from Brazil on 2012-02-17

Patient: female, weighing 110.0 kg (242.0 pounds)

Reactions: Confusional State, Pneumonia, Diabetic Complication, Secretion Discharge, Somnolence, Speech Disorder, Blood Glucose Decreased, Eyelid Function Disorder, Tongue Disorder

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Diazepam; Captopril; Haloperidol; Nortriptyline HCL; Insulin



Possible Depakene side effects in 37 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-01

Patient: 37 year old male

Reactions: Confusional State, Agitation, Drug Level Increased, Encephalopathy, Hallucination

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-17

Patient: female

Reactions: Confusional State, Cognitive Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: ALL Other Therapeutic Products; Raloxifene; Nitroglycerin; Lorazepam; Aspirin; Levothyroxine Sodium



Possible Depakene side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-01-13

Patient: 29 year old female

Reactions: Confusional State, Drug Level Increased, Ataxia, Disorientation, Speech Disorder, Disturbance in Attention, Vision Blurred, Ammonia Increased, Memory Impairment, Hypersomnia

Drug(s) suspected as cause:
Depakene
    Dosage: gastro-resistant tablet daily
    Indication: Obsessive-Compulsive Disorder

Depakene
    Dosage: gastro-resistant tablet daily
    Indication: Bipolar Disorder

Other drugs received by patient: Fluvoxamine Maleate; Clonazepam; Fluvoxamine Maleate; Clonazepam



Possible Depakene side effects in male

Reported by a pharmacist from Japan on 2011-12-22

Patient: male

Reactions: Confusional State, Pneumonia Aspiration, Intentional Overdose, Coma, Pyrexia, Hyperhidrosis, Anticonvulsant Drug Level Increased, Bundle Branch Block, Eye Movement Disorder, Mydriasis, Restlessness, Myoclonus, Grand MAL Convulsion, Respiratory Failure, Hallucination, Visual, Suicide Attempt, Hypertension, Altered State of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 16000 mg, unk
    Start date: 2010-11-30

Desyrel
    Dosage: 2250 mg, unk
    Start date: 2010-11-30

Nitrazepam
    Dosage: 70 mg, unk
    Administration route: Oral
    Start date: 2010-11-30

Selegiline HCL
    Dosage: 195 mg, unk
    Administration route: Oral
    Start date: 2010-11-30

Selegiline HCL
    Dosage: 10 mg, daily
    Indication: Depression
    Start date: 2005-05-01

Tegretol
    Dosage: 8600 mg, unk
    Administration route: Oral
    Indication: Bipolar I Disorder
    Start date: 2010-11-30
    End date: 2010-11-30

Other drugs received by patient: Rohypnol; Brotizolam; Dogmatyl; Zyprexa



Possible Depakene side effects in 77 year old female

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2011-12-13

Patient: 77 year old female

Reactions: Confusional State, Listless, Memory Impairment

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Paroxetine HCL; Amlodipine



Possible Depakene side effects in 29 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2011-12-08

Patient: 29 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Confusional State, Self Injurious Behaviour, Intentional Drug Misuse, Asthenia

Drug(s) suspected as cause:
Alcohol
    Indication: Product Used FOR Unknown Indication

Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

EN
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Marijuana
    Indication: Product Used FOR Unknown Indication

Promazine Hydrochloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Valium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Depakene side effects in male

Reported by a consumer/non-health professional from Brazil on 2011-11-23

Patient: male, weighing 52.0 kg (114.4 pounds)

Reactions: Osteoarthritis, Confusional State, Anaemia

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Convulsion

Edhanol
    Administration route: Oral
    Indication: Convulsion

Other drugs received by patient: Phenobarbital TAB



Possible Depakene side effects in 77 year old female

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2011-11-09

Patient: 77 year old female

Reactions: Confusional State, Listless, Memory Impairment

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Amlodipine; Paroxetine HCL



Possible Depakene side effects in 62 year old female

Reported by a consumer/non-health professional from China on 2011-10-28

Patient: 62 year old female

Reactions: Confusional State, Intentional Overdose, Chills, Suicide Attempt

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: gastro-resistant, once
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-12

Depakene
    Dosage: 50 dosage form; gastro-resistant; once
    Administration route: Oral
    Indication: Depression
    Start date: 2011-10-12
    End date: 2011-10-12

Other drugs received by patient: Olanzapine



Possible Depakene side effects in 32 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-21

Patient: 32 year old male

Reactions: Confusional State, Pneumonia Aspiration, Hyperammonaemia, Pyrexia, Somnolence, Asthenia, Leukocytosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: daily
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-02-10
    End date: 2010-03-09

Depakene
    Indication: Mental Disorder

Other drugs received by patient: Urbanyl; Clozapine; Haldol



Possible Depakene side effects in 62 year old female

Reported by a consumer/non-health professional from China on 2011-10-18

Patient: 62 year old female

Reactions: Confusional State, Intentional Overdose, Chills, Suicide Attempt

Drug(s) suspected as cause:
Depakene
    Dosage: gastro-resistant, once
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-12

Depakene
    Dosage: gastro-resistant
    Administration route: Oral
    Indication: Depression
    Start date: 2010-01-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017